June 2021 – Nectar Health Sciences

Paul Carpanini

CEO & Director

Paul brings over 25 years of experience in mergers and acquisitions , international market expansion and marketing institutional investment management services. Through his experience and qualifications, he has a demonstrated ability in leadership, sound business practices and a track record of assisting with many entrepreneurial start-up ventures. Paul has a solid background in Corporate Business Development and is committed to help uncover new specialized markets and niche opportunities in order to grow the business.

Barry Perlmutter

Director

Barry is currently President and Managing Director of BHS-Filtration Inc., a subsidiary of BHS-Sonthofen GmbH. BHS is a manufacturer of filtration and drying technologies. Barry has over 35 years of technical engineering and business marketing experience in the field of solid-liquid separation including filtration and centrifugation and process drying. He has published and lectured extensively worldwide on the theory and applications for the chemical, pharmaceutical and energy / environmental industries and has been responsible for introducing and creating growth for many European companies and technologies into the marketplace.

Barry began his career with the US Environmental Protection Agency. He received a BS degree in Chemistry from Albany State (NY) University, MS degree from the School of Engineering at Washington University, St. Louis and an MBA from the University of Illinois. Barry served on the Board of Directors of the American Filtration

Dan Polonenko, PhD

Director

Dan Polonenko is a principal and patent agent in the Calgary office of Gowling WLG. His practice involves patent drafting and prosecution in the fields of life sciences, focusing on biotechnology, health, medical devices, agriculture and forestry, oil and gas, energy, clean tech, environmental technologies, process engineering, and mechanical inventions. Additionally, Dan provides business-focused strategic intellectual property (IP) and technology commercialization services.

Dan is a member of the firm’s Chemistry, Technology, Life Sciences, and Patent Prosecution groups.

A registered patent agent in both Canada and the United States, Dan has over 20 years of experience in the Canadian biotech industry, including seven years at the executive levels at two companies. During his scientific and business careers, Dan co-authored 20 peer-reviewed scientific publications and several book chapters. As an inventor, Dan is a co-inventor of six issued patent families.

Scott Lindsay

Director

Mr. Lindsay was a co-founder of the Canadian based Shipping Agency and Brokerage Company, Pacific Northwest Ship & Cargo Services Ltd., was a managing partner of Seaspan (Cyprus) Ltd. (affiliated with the Washington Marine Group), and is a now the President & Director of Seabridge Marine Services Ltd. (Canada), and a director of various Corporate entities of the Seabridge Marine Group in both Canada and Asia as well as the Chairman of Terasea Pte Ltd. and a director of POSH Terasea Pte Ltd. The companies are specialists in heavy lift transportation, offshore towage, barging, and vessel construction.

Born and raised in Vancouver Canada, Mr. Lindsay holds a DipT in Administration and a Bachelor’s Degree in Business Administration. With his over 25 years of business management experience focused on International Shipping and Transportation, he has always been active in and around the waters of British Columbia and the World on both a personal and professional level.

News